These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3565107)

  • 1. An investigation of withdrawal symptoms shown by opiate addicts during and subsequent to a 21-day in-patient methadone detoxification procedure.
    Gossop M; Bradley B; Phillips GT
    Addict Behav; 1987; 12(1):1-6. PubMed ID: 3565107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opiate withdrawal symptoms in response to 10-day and 21-day methadone withdrawal programmes.
    Gossop M; Griffiths P; Bradley B; Strang J
    Br J Psychiatry; 1989 Mar; 154():360-3. PubMed ID: 2688778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the withdrawal responses of heroin and methadone addicts during detoxification.
    Gossop M; Strang J
    Br J Psychiatry; 1991 May; 158():697-9. PubMed ID: 1860023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety, efficacy, and long-term results of a modified version of rapid opiate detoxification under general anaesthesia: a prospective study in methadone, heroin, codeine and morphine addicts.
    Hensel M; Kox WJ
    Acta Anaesthesiol Scand; 2000 Mar; 44(3):326-33. PubMed ID: 10714849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of linear versus inverse exponential methadone reduction curves in the detoxification of opiate addicts.
    Strang J; Gossop M
    Addict Behav; 1990; 15(6):541-7. PubMed ID: 2075851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the dose on the severity of opiate withdrawal symptoms during methadone detoxification.
    Glasper A; Gossop M; de Wet C; Reed L; Bearn J
    Pharmacology; 2008; 81(2):92-6. PubMed ID: 17952010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methadone at tapered doses for the management of opioid withdrawal.
    Amato L; Davoli M; Ferri M; Ali R
    Cochrane Database Syst Rev; 2003; (2):CD003409. PubMed ID: 12804464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Craving and drug reward: a comparison of methadone and clonidine in detoxifying opiate addicts.
    Dawe S; Gray JA
    Drug Alcohol Depend; 1995 Oct; 39(3):207-12. PubMed ID: 8556969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individuals.
    Law FD; Diaper AM; Melichar JK; Coulton S; Nutt DJ; Myles JS
    J Psychopharmacol; 2017 Aug; 31(8):1046-1055. PubMed ID: 28631527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Is premature termination of opiate detoxification due to intensive withdrawal or craving?].
    Scherbaum N; Heppekausen K; Rist F
    Fortschr Neurol Psychiatr; 2004 Jan; 72(1):14-20. PubMed ID: 14745685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised double-blind comparison of lofexidine and methadone in the in-patient treatment of opiate withdrawal.
    Bearn J; Gossop M; Strang J
    Drug Alcohol Depend; 1996 Dec; 43(1-2):87-91. PubMed ID: 8957147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major disruptions of sleep during treatment of the opiate withdrawal syndrome: differences between methadone and lofexidine detoxification treatments.
    Beswick T; Best D; Rees S; Bearn J; Gossop M; Strang J
    Addict Biol; 2003 Mar; 8(1):49-57. PubMed ID: 12745416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical effectiveness of electrostimulation vs oral methadone in managing opiate withdrawal.
    Gossop M; Bradley B; Strang J; Connell P
    Br J Psychiatry; 1984 Feb; 144():203-8. PubMed ID: 6608391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of buspirone in the treatment of opioid withdrawal.
    Buydens-Branchey L; Branchey M; Reel-Brander C
    J Clin Psychopharmacol; 2005 Jun; 25(3):230-6. PubMed ID: 15876901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonidine versus long- and short-term methadone-aided withdrawal from opiates. An uncontrolled comparison.
    Kasvikis Y; Bradley B; Gossop M; Griffiths P; Marks I
    Int J Addict; 1990 Oct; 25(10):1169-78. PubMed ID: 2090621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of buspirone in withdrawal from opiates.
    Rose JS; Branchey M; Wallach L; Buydens-Branchey L
    Am J Addict; 2003; 12(3):253-9. PubMed ID: 12851021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypercortisolism after opioid discontinuation in rapid detoxification of heroin addicts.
    Camí J; Gilabert M; San L; de la Torre R
    Br J Addict; 1992 Aug; 87(8):1145-51. PubMed ID: 1511228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetyl-L-carnitine in the management of pain during methadone withdrawal syndrome.
    Janiri L; Martinotti G; Tonioni F; Ghelardini C; Nicolai R; Galeotti N; Mosconi L; Calvani M; Bartolini A; Iannoni E
    Clin Neuropharmacol; 2009; 32(1):35-40. PubMed ID: 18978503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans.
    Donny EC; Walsh SL; Bigelow GE; Eissenberg T; Stitzer ML
    Psychopharmacology (Berl); 2002 May; 161(2):202-12. PubMed ID: 11981600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated lofexidine treatment regimen compared with conventional lofexidine and methadone treatment for in-patient opiate detoxification.
    Bearn J; Gossop M; Strang J
    Drug Alcohol Depend; 1998 May; 50(3):227-32. PubMed ID: 9649976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.